Very interesting session with speakers from Japan, India, Slovenia, Jordan, South Africa and South Korea. Language matters, cultural sensitivity even more, particularly in Quality of Life Research. There’s work to do! Happy to have introduced the topic showing other global activities @eortc.org

🔔 New in @thelancetoncol.bsky.social: Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer. 📖Read more: www.eortc.org/blog/2025/09... #CancerResearch #QualityofLife

📅 Get ready to make the most of EORTC’s upcoming events! Mark your calendars 👇 #CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26

📅 Attending ESMO in Berlin? Don't miss this special CSO Symposium taking place on Fri Oct 17, 5:30-7:00 pm CET. Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond. tinyurl.com/5yj9vm8b @qol.eortc.org #CommonSenseOncology

Applications for the 2026 Common Sense Oncology Cancer Health Services Research Fellowship will close on Sept 18, 2025 @ 4 pm EDT. If you are in the clinical or medical oncology field, this opportunity is for you! View the posting online: tinyurl.com/37cdc5sy #CommonSenseOncology #CancerCare

Common Sense Oncology is now on #BlueSky! We are a global network dedicated to advancing innovative patient-centred cancer care & cancer research that meaningfully improves outcomes for patients around the world. Join us to keep in touch—membership is free! tinyurl.com/mrjtu9at #CommonSenseOncology

Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation - The Lancet Global Health www.thelancet.com/journals/lan... This is awful.

📢Excited to announce @benjaminbessemd.bsky.social as EORTC President-Elect, starting in June 2026, following @winettevandergraaf.bsky.social 🙌 Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉 👉 www.eortc.org/blog/2025/06...

🔍Presenting at #ASCO25 as a #poster and now LIVE on our website Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study Read the whole paper here: www.thelancet.com/journals/ecl... #TheLancet #Oncology #OncologyResearch #MedSky

Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer Primary prophylactic G-CSF and loperamide led to a clinically relevant reduced incidence and severity of neutropenia and diarrhea www.thelancet.com/journals/ecl... #MedSky

New paper on implementation of WGS in sarcoma routine medical care in a sarcoma expert center. WGS results of 161 STS were assessed. Actionable targets in 46%, subtype specific added value of WGS. Less in fusion pos STS, more in complex ones. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

Immensely proud of my colleague and friend Christopher Booth @Queens’s University Kingston who will present the positive results of Challenge #ASCO25 today. Together with Publication in @nejm.org Impressive work. meetings.asco.org/2025-asco-an...

A new paper from a workshop on pragmatic clinical trials in cancer organised by @eortc.org published in Lancet Oncology. Fabulous group of co-authors who took part in the workshop. Access to drugs that matter to patients as ultimate goal. eur05.safelinks.protection.outlook.com?url=https%3A...

Easter in #Amsterdam

🤝As the clinical trial landscape evolves, so must our strategies for measuring patients’ #QualityofLife to ensure their voice is incorporated in the decision-making process 🔎Takeaways from new article in @thelancetoncol.bsky.social: www.eortc.org/blog/2025/04... #GivingVoice2Patients @ema.europa.eu

The paper is out! #Sarcoma genetic predisposition syndromes. Consequences for diagnosis and treatment. Result of an educational session at @ESMO annual meering 2023. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

Very interesting presentation by @rubenvanboxtel.bsky.social at Clinical Cancer Genomics conference Amsterdam. One part of the puzzle of rising incidence of Young Onset CRC addressed with pks mutations.

Great start of Clinical Genomics conference Amsterdam @ecuppen.bsky.social Very useful oversight of genomic activities in Europe! @stefanfrohling.bsky.social

EuropePMC.org is the alternative for PubMed, in case you have problems to access PubMed.

You can freely access all PubMed records at Europepmc.org - I just checked and it's up and running.

#REVIEW 🚨 In our Feb. issue, Wang & Zhang summarize findings from genetic & epigenetic association studies performed on cohorts of survivors of childhood cancer, providing insights into the long-term adverse effects related to cancer therapy. 📖 👇 https://bit.ly/4eplZ...

It's not "Breaking News" now, since it was announced by NIH yesterday. But it is breaking....... washingtonpost.com/health/2025/...

Reposting so I can tag with #Medsky

My 2nd World Cancer Day post to highlight work of the Common Sense Oncology team. This new publication identifies key principles for randomized trials of new cancer Rx aimed at improving outcomes that matter most to patients www.sciencedirect.com/science/arti...

on World Cancer Day it’s important to underscore the HUGE impact academic cancer trials groups e.g @cctg.bsky.social and @eortc.bsky.social have had on improving outcomes. Their studies of new drugs, radiation, surgery & supportive care all have contributed. Pharma is only part of the story.

Fascinating paper on how different races/ethnicities respond differently to anticancer therapies - such an important thing to understand for personalised medicine #CancerResearch aacrjournals.org/cancerdiscov...

Urgent action is needed to scale-up cancer prevention and care services. Cancer registries can play a crucial role in this. Ahead of #WorldCancerDay, our Editorial explores the benefits and challenges of cancer registries in global cancer care: tinyurl.com/ywpr6e37

✅ I started an #AYACSM (Adolescent and Young Adult Cancer Societal Movement) starter pack! ⭐ This is the beginnings of gathering all of us around the globe 🌍 who are involved in #AYACancer work/advocacy 💡 Please share and let me know who you would like to have added! go.bsky.app/Vfp4JWE

Important findings! #Sarcsky

Bizarre story. Genetic Analysis of a Sarcoma Accidentally Transplanted from a Patient to a Surgeon | New England Journal of Medicine www.nejm.org/doi/full/10....

Interesting data from India by Jyoti Bajpai and colleagues on #AYA with bone #sarcomas emphasizing the role of treatment according to existing protocols and timely referrals for fertility preservation before starting the intensive chemotherapy trajectories. pubmed.ncbi.nlm.nih.gov/39297373/

Clinical Cancer Genomics 2025: two more weeks till registration deadline! Check out the website for detailed program and speakers. The meeting includes a session with presentations from all major cancer whole genome sequencing initiatives in Europe. www.ccg2025.eu

This paper describes a large diversity in histological and radiological response patters to neoadjuvant Radiotherapy in a series of 107 patients with soft tissue #sarcoma treated at @nkinl.bsky.social Subtype matters! Best volume response in #mLPS. pubmed.ncbi.nlm.nih.gov/39699680/

Global study reveals shifting trends in ovarian cancer incidence by subtype and region 🌎📊💉 www.news-medical.net/news/2024121... #OvarianCancer #GlobalHealth #CancerResearch #Epidemiology #WomensHealth #PublicHealth #Oncology

That's a lot of parameters for a large language model. The human brain has ~100 trillion. About 60X GPT-4.

Early-onset colorectal cancer on the rise globally. 🚨Rates are increasing in 27/50 countries. 🚨🙋🏻‍♂️🙋‍♀️and younger adults face alarming trends. Awareness and early detection are critical! @oncoalert.bsky.social @realbowtiedoc.bsky.social @viveksubbiah.bsky.social www.thelancet.com/journals/lan...

The 7th masterclass of #sarcoma and #rarecancers in Athens is a great place for education and excellent discussions ànd seeing #bluesky!

Great interview (in Dutch) about neoadjuvant immunotherapy: impressive results in dMMR CRC. Who knows also for other less well-studied tumors or immuno ‘cold’ tumors in the future… subject of ongoing research by Myriam Chalabi and team at @nkinl.bsky.social

Nice collaboration with a.o. Ana Ribeiro PhD student & Prof Christina Messiou @icrlondon.bsky.social & @ddocc.bsky.social &Olga Husson @nkinl.bsky.social "Perspectives on access to imaging digital health records in oncology: A mixed methods systematic review": www.sciencedirect.com/science/arti...

📢 Applications for the NKI PhD program open from Jan 1 - Feb 28. Join our international research community in Amsterdam, working in cancer biology, AI research & life sciences with leading scientists and top facilities #PhD #CancerResearch More info: bit.ly/3O4bOjq

Future PhD students, check out our NKI PhD program: bsky.app/profile/nkin...

A number of #AYA cancer survivors experience insurance and financial hardships, including foregoing medical care due to financial constraints, problems paying medical bills, and difficulties accessing loans or insurances. #survonc #ayacsm link.springer.com/article/10.1...

It’s out in @natureportfolio.bsky.social the SONIA study, led by Gabe Sonke, Agnes Jager and Inge Konings - 👏👏👏

Led by Miranda Fidler-Benaoudia. AYA cancer globally will increase ca 12% from 2022-2050. Huge impact on low HDI countries (incidence and mortality). The current and future global burden of cancer among adolescents and young adults: a population-based study": www.sciencedirect.com/science/arti...

ASCO annual meeting 2025 abstract submitter open - closes Jan 28th. To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)! Apply for a waiver when you submit an abstract conferences.asco.org/am/abstract-...

Moved from X to this medium hoping to find the interesting content Twitter once had.